Author

Samantha Eichner 1

1 AbbVie Inc.

LONG-TERM EFFECTIVENESS OF ADALIMUMAB IN CROHN’S DISEASE: OBSERVATIONAL DATA FROM THE PYRAMID REGISTRY

Edward Loftus, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Roopal B Thakkar, Samantha Eichner, Majin M. Castillo, Natalia Kan-Dobrosky, Martha Skup, Parvez Mulani, Jingdong Chao

LONG-TERM EFFICACY OF ADALIMUMAB IN PAEDIATRIC PATIENTS WITH CROHN’S DISEASE

William A Faubion, Frank Ruemmele, Andreas Lazar, Samantha Eichner, Nattanan Reilly, Roopal B Thakkar

LONG-TERM SAFETY OF ADALIMUMAB IN PAEDIATRIC PATIENTS WITH CROHN’S DISEASE

Robert Baldassano, Frank Ruemmele, William A Faubion, Jiri Kierkus, Jeffrey S Hyams, Andreas Lazar, Yaqin Wang, Samantha Eichner, Roopal B Thakkar

PYRAMID REGISTRY: AN OBSERVATIONAL STUDY OF ADALIMUMAB IN CROHN’S DISEASE: RESULTS AT YEAR 5

Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Edward Loftus, Jr, Remo Panaccione, Majin M. Castillo, Natalia Kan-Dobrosky, Samantha Eichner, Roopal B Thakkar

RELATIONSHIP OF THE PEDIATRIC CROHN’S DISEASE ACTIVITY INDEX (PCDAI) AND CROHN’S DISEASE ACTIVITY INDEX (CDAI) IN IMAGINE 1

Dan Turner, Jeffrey S Hyams, Marla Dubinksy, William A Faubion, Samantha Eichner, Yao Li, Andreas Lazar, Bidan Huang, Roopal B Thakkar

Item 11 - 15 / 15
1
2